Robert F. Anderson - Concepedia

Author

Robert F. Anderson

Also Known As

Anderson, R., Anderson, R.F., Anderson, Robert, Anderson, Robert F., Anderson, Robert F. (Robert Francis), R Anderson, R F Anderson, R. Anderson, R. F. ANDERSON, R. F. Anderson

212

Publications

4.7K

Citations

H-Index

112

Concepts

All Affiliations

University of Auckland Cancer Society of New Zealand Mount Vernon Hospital University of Otago

About

Robert F. Anderson is an author at University of Auckland specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	45	2K
2	Natural Sciences	29	47	1.9K
3	Engineering	16	19	722
4	Health Sciences	5	5	219
5	Anatomy	1	1	22

Robert F. Anderson

101

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302 Fanying Meng, James Evans, Deepthi Bhupathi, Molecular Cancer Therapeutics PharmacotherapyRedox BiologyOxidative StressMolecular PharmacologyRedox Regulator	2011	203
Green tea catechins partially protect DNA from middle dotOH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals Robert F. Anderson Carcinogenesis	2001	176
Energetics of the one-electron reduction steps of riboflavin, FMN and FAD to their fully reduced forms Robert F. Anderson Biochimica et Biophysica Acta (BBA) - Bioenergetics EngineeringBiochemistryNatural SciencesRadical (Chemistry)One-electron Reduction Steps	1983	113
Activation of 3-Amino-1,2,4-benzotriazine 1,4-Dioxide Antitumor Agents to Oxidizing Species Following Their One-Electron Reduction Robert F. Anderson, S.S. Shinde, Michael P. Hay, Journal of the American Chemical Society	2002	111
Structure−Activity Relationships of 1,2,4-Benzotriazine 1,4-Dioxides as Hypoxia-Selective Analogues of Tirapazamine Michael P. Hay, Swarna A. Gamage, Mary S. Kovacs, Journal of Medicinal Chemistry Pharmaceutical ScienceHypoxia-selective AnaloguesPharmacotherapyChemistryHeterocycle Chemistry	2002	111
Reactions of Superoxide with Myeloperoxidase Anthony J. Kettle, Robert F. Anderson, Mark B. Hampton, Biochemistry	2007	97
MitoNeoD: A Mitochondria-Targeted Superoxide Probe Maria M. Shchepinova, Andrew G. Cairns, Tracy A. Prime, Cell chemical biology BiochemistryMitochondrial FunctionNatural SciencesMolecular BiologyMitochondria-targeted Superoxide Probe	2017	97
Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824) Andrew M. Thompson, Adrian Blaser, Robert F. Anderson, Journal of Medicinal Chemistry Organic ChemistryPharmacotherapyHeterocycle ChemistryChemical BiologyPharmaceutical Chemistry	2008	92
Tricyclic [1,2,4]Triazine 1,4-Dioxides As Hypoxia Selective Cytotoxins Michael P. Hay, Kevin O. Hicks, Karin Pchalek, Journal of Medicinal Chemistry	2008	71
The Reaction Mechanism of Xanthine Oxidase: Evidence for Two-Electron Chemistry Rather Than Sequential One-Electron Steps Amy Stockert, S.S. Shinde, Robert F. Anderson, Journal of the American Chemical Society Molybdenum Redox CyclesOxygen Reduction ReactionEngineeringBiochemistryNatural Sciences	2002	71

Page 1